Clinical Trials

Long term, prospective, multi-national, parallel-cohort, study monitoring safety in patients with MS newly started on fingolimod once daily or treated with another approved disease modifying therapy.


Research Study Number:
W-20120269

Short Title:
PASSAGE

Division:
Neuroscience Institute

Study Status:
Enrolling